Navigation Links
HUYA Bioscience International and Tianjin International Joint Academy of Biotechnology and Medicine Form Alliance
Date:10/18/2011

SAN DIEGO, Oct. 18, 2011 /PRNewswire/ -- HUYA Bioscience International, a leader in globalizing China's biopharmaceutical innovations, today announced a strategic alliance with the Tianjin International Joint Academy of Biotechnology and Medicine (TJAB). The alliance will unite the strength and resources of both parties to accelerate the development of China's biomedical innovation and industrialization.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutions throughout China and has pioneered in-licensing both preclinical and clinical stage compounds from the country, utilizing its expertise to advance these compounds for global markets.

TJAB, a state of the art pharmaceutical research & development platform, was jointly established by the Ministry of Science and Technology, the Ministry of Commerce, the Ministry of Health, the State Food and Drug Administration, and Tianjin Municipality.  It was established with the vision of creating China's International Innovation Zone of Biotechnology and Medicine (BioMed Zone) to boost China's biomedical industry. Situated at the heart of the Tianjin Binhai New Area, TJAB  has attracted more than 100 research & development groups, focusing in the areas of infectious diseases, cancer, diabetes, and hypertension.

Under the agreement, TJAB and HUYA will collaborate to promote new drug development. HUYA will have the first opportunity to provide assistance in evaluating research and development projects conducted by enterprises residing in TJAB. HUYA will also be able to globalize select programs from TJAB through HUYA's innovative co-developme
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015   Mast ... biopharmaceutical company leveraging its molecular adhesion and sealant ... sickle cell disease, heart failure, and arterial disease, ... EPIC study of its lead product ... surpassed the halfway point. Consistent with prior guidance, ...
(Date:4/21/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5jt68c/global_api_market ) has ... 2018" report to their offering. Global API ... the Global API industry is expected to grow at a ... been divided into four major geographies which comprise Americas, ... the rest of the world. For every region, a current ...
(Date:4/21/2015)... MENLO PARK, Calif. , April 21, 2015 /PRNewswire/ ... company focused on the emerging field of regenerative medicine, ... patients with acute myelogenous leukemia (AML) from the Phase ... cell cancer vaccine, AST-VAC1, has been selected for an ... Oncology (ASCO) Annual Meeting, to be held in ...
Breaking Medicine Technology:Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 2Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 3Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 4Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 5Global API Market Outlook Report 2014-2018 2Global API Market Outlook Report 2014-2018 3Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 2Asterias Biotherapeutics Announces Phase 2 Clinical Data on Autologous Telomerase-based Dendritic Cell Cancer Vaccine AST-VAC1 Selected for Oral Presentation at the 2015 ASCO Annual Meeting 3
... , ... Albemarle Corporation (NYSE: ALB ), a leading global ... PharmaCore to provide manufacturing capabilities for customers with projects that require ... alliance allows a seamless technology transfer from PharmaCore to Albemarle ...
... , ... Systems, Inc. today announced full integration between AVImark veterinary software ... the two-way connection allows diagnostic test requisitions and patient data ... any AVImark workstation in a veterinary practice. Test results are ...
Cached Medicine Technology:Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 2Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 3Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 4Albemarle(R) Announces Custom Manufacturing Alliance with PharmaCore(R) 5McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010 2McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010 3McAllister Software Systems, Inc. and IDEXX Laboratories, Inc. Announce Availability of the IDEXX VetLab(R) Station InterLink(TM) Connection to AVImark(R) 2010 4
(Date:4/21/2015)... has released a new blog post explaining the importance of ... on a uto insurance prices . , Drivers ... for advantageous auto insurance discounts. Clients can now review multiple ... will also help them get the best rates in their ... cost coverage is no longer difficult as there are multiple ...
(Date:4/21/2015)... Collierville, TN (PRWEB) April 21, 2015 ... health care leaders get better results from their safety ... toolkit, available free, provides specific guidelines and proven ways ... safety programs. , Spurred by the Affordable Care Act, ... on safety and quality metrics rather than the volume ...
(Date:4/21/2015)... When a bandage sticks to an injury ... to solve this problem two inventors from Festus, Mo., ... bandage helps a cut, burn, abrasion or wound heal ... exposure. The bandage is easy to use, versatile and ... submitted to the St. Louis office of InventHelp. It ...
(Date:4/21/2015)... April 21, 2015 A new study ... among patients with peritoneal cancers like mesothelioma increased by ... has just posted the results of the study. ... , Doctors at North Hampshire Hospital in Basingstoke performed ... malignancies such as mesothelioma between 1994 and ...
(Date:4/21/2015)... MO (PRWEB) April 21, 2015 The ... 2015 from 5:00 to 8:00 pm at the William and ... Chapel Hill, NC 27599. More than 50 hospitals, clinics and ... country. All specialties will be represented. Attendees will enjoy free ... of Career Fairs for PracticeMatch says “Chapel Hill ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes Offer Excellent Security for A Car 2Health News:LifeWings Announces New Physician Engagement Toolkit to Help Hospitals Weather Serious Ramifications of the Affordable Care Act 2Health News:New Findings Highlight Value of Experience in Peritoneal Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 2Health News:PracticeMatch to Host Physician Career Fair at William and Ida Friday Center at UNC-Chapel Hill on April 29, 2015 3
... infants are of particular concern to thyroid experts , ... their salt consumption, thyroid experts worry that some may ... important source of dietary iodine in the U.S. and ... is obtained solely through diet," several members of the ...
... a mechanism by which an enzyme regulates gene expression ... someday lead to more effective drugs to attack cancers ... serious type of skin cancer, is highly resistant to ... understood. New research at VCU suggests that an enzyme ...
... DC (June 17, 2010)The Alliance for Academic Internal Medicine (AAIM) ... medical education (GME) funding. In light of the ... Advisory Commission,s (MedPAC,s) June 2010 report, AAIM encourages GME reform ... needs. The AAIM Principles for GME ...
... ... now offers a full Live Insurance Mapping solution for laboratories. , ... (PRWEB) June 17, 2010 -- ELLKAY ... is a unique technology that assists laboratories in reducing their bad debts and increases ...
... Knowledge ... Europe, and this year they’ll open new offices in Singapore, Australia and New Zealand. ... Fulham, London (PRWeb UK) June ... Life Magazine. The e-zine, scheduled to launch this month, will help readers discover more about ...
... Investments in the future of health care delivery include ... technology (health IT) specialists are critical. While ... offer their patients the benefits of electronic medical records ... of highly skilled health IT workers to fill an ...
Cached Medicine News:Health News:Iodine Levels a Worry as Salt Use Declines 2Health News:Researchers identify key enzyme in melanoma cell development 2Health News:ELLKAY Introduces Revolutionary Live Insurance Mapping Solution for Diagnostic Laboratories 2Health News:ELLKAY Introduces Revolutionary Live Insurance Mapping Solution for Diagnostic Laboratories 3Health News:ELLKAY Introduces Revolutionary Live Insurance Mapping Solution for Diagnostic Laboratories 4Health News:Knowledge To Action and Greg Secker Announce Launch of Richer Life Magazine 2Health News:IU and Regenstrief address critical need for health IT professionals 2
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
Mastisol Liquid Adhesive is a clear, non-irritating, and non-water-soluble liquid adhesive that secures the most difficult dressings for an extended period of time. Mastisol is 7 to 10 times stickier...
GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
... GE Healthcare is ... in best-in-class analysis programs ... area monitoring device. With ... 12SL, Gender-Specific, and ACI-TIPI, ...
Medicine Products: